JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayer, S. E.
Right arrow Articles by Bain, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayer, S. E.
Right arrow Articles by Bain, J. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Journal of Pharmacology And Experimental Therapeutics, Vol. 118, Issue 1, 1-16, 1956
Copyright © 1956 by American Society for Pharmacology and Experimental Therapeutics


THE INTRACELLULAR LOCALIZATION OF FLUORESCENT CONVULSANTS

Steven E. Mayer 1 and J. A. Bain 1

1 Departments of Pharmacology, College of Medicine, University of Illinois, Chicago, and Division of Basic Health Sciences, Emory University, Georgia

The intracellular localization of two convulsant acridone derivatives has been studied by means of fluorescence microscopy with the following results:

1) The convulsant, 10(2-diethylaminoethyl)-9-acridone, localizes in the nuclei of central nervous system cells with the most intense fluorescence occurring in the nucleoli and in some cases the nuclear membrane. This can be demonstrated immediately after minimal convulsant doses in rats and cats. Certain neuronal types, the cerebellar Purkinje cells and the retinal neurones other than the inner nuclear layer, do not show this characteristic pattern. With the exception of the kidney and the adrenal medulla, nuclear fluorescence of other organs is of much lower intensity.

2) The more potent convulsant, 10(2-dimethylaminopropyl)-9-acridone, can be visualized only after doses at least three times the convulsant threshold. Under these circumstances it localizes much more diffusely within the central nervous system cells than the diethyl derivative.

The possible relationships between the localization of these drugs and their site of action as convulsants is discussed in terms of the contrast between acridones and other vital nuclear dyes, their site of binding in the nucleus, and the hypothetical role of the nuclei of the nerve cell bodies within the central nervous system in the mechanism of convulsions.

Some additional data on the gross distribution of 10(2-diethylaminoethyl)-9 acridone, based on direct chemical analysis, are also reported.

Submitted on March 12, 1956







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1956 by the American Society for Pharmacology and Experimental Therapeutics.